SBRT for recurrent head and neck cancer

Research output: Contribution to journalArticle

Abstract

The management of patients with recurrent head and neck cancers is complex. Concerns over toxicity with re-irradiation have limited its use in the clinical setting. Stereotactic Body Radiation Therapy (SBRT) has emerged as a highly conformal and precise type of radiotherapy and has the advantage of sparing normal tissue. Although SBRT is an attractive treatment modality, its use in the clinic is limited, given the technically challenging nature of the procedure. In this review, we attempt to provide a comprehensive overview of the role of re-irradiation in patients with recurrent head and neck cancers, with particular attention to the advent of SBRT and its use with systemic therapies such as cetuximab.

Original languageEnglish (US)
Article number012025
JournalJournal of Physics: Conference Series
Volume777
Issue number1
DOIs
Publication statusPublished - Feb 3 2017

    Fingerprint

ASJC Scopus subject areas

  • Physics and Astronomy(all)

Cite this